Mittal Abhenil, Pushpam Deepam, Kumar Lalit
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Room no 245, DRBRAIRCH, New Delhi, India.
Leuk Res Rep. 2020 Jun 8;14:100207. doi: 10.1016/j.lrr.2020.100207. eCollection 2020.
•CNS relapse in multiple myeloma after ASCT without medullary relapse is uncommon.•Isolated CNS relapse is extremely rare with only 7 cases reported in literature.•Prognosis is poor with very short median survival after detection of CNS relapse.•Management is based on IMiD's and intrathecal therapy with radiation.
•自体造血干细胞移植(ASCT)后无髓内复发的多发性骨髓瘤中枢神经系统(CNS)复发并不常见。
•孤立性CNS复发极为罕见,文献中仅报道了7例。
•CNS复发检测后中位生存期极短,预后较差。
•治疗基于免疫调节药物(IMiD)和鞘内注射联合放疗。